Susan Greenbloom

Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials

Silvio Danese, Séverine Vermeire, Wen Zhou et al. · The Lancet · 2022 · 544 citations

Anti-inflammatory, Systemic Treatment, Gastroenterology +7

Cilofexor, a Nonsteroidal FXR Agonist, in Patients With Noncirrhotic NASH: A Phase 2 Randomized Controlled Trial

Keyur Patel, Stephen A. Harrison, Magdy Elkhashab et al. · Hepatology · 2020 · 311 citations

Combination Ciprofloxacin and Metronidazole for Active Crohn’s Disease

Susan Greenbloom, A. Hillary Steinhart, Gordon R. Greenberg · Canadian Journal of Gastroenterology · 1998 · 168 citations · Full text

A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection

Andrew J. Muir, Sanjeev Arora, Gregory T. Everson et al. · Journal of Hepatology · 2014 · 142 citations

Viral Persistence, Viral Hepatitis, Antiviral Therapy +8

Randomized, double-blind, placebo-controlled trial of the oral interleukin-12/23 inhibitor apilimod mesylate for treatment of active Crohn's disease

Bruce E. Sands, Eric Jacobson, Thomas Sylwestrowicz et al. · Inflammatory Bowel Diseases · 2009 · 108 citations